Vice President of business development

Transforming the future of precision therapeutics together

We are leveraging the power of the dark genome to develop precise and potent RNA therapies for reprogramming disease driving cell-states.

We tackle disease at its source by identifying and addressing the right Target, Place, Time, and Way to accelerate the development of the next-generation of dark genome targets and therapeutics for underserved rare and chronic diseases.

Our mission is to identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility.

Inspired to transform,
the genome informs

We are looking for a Vice President of Business Development to join our team!

HAYA Therapeutics seeks an accomplished and strategic Vice President of Business Development to join our dynamic team. You will be critical in driving HAYA’s growth strategy, identifying and evaluating new business opportunities, and forming strategic partnerships. To excel in this role, you need deep biotech/pharma industry knowledge, a strong scientific background, and excellent interpersonal skills.

This position will be at Haya Therapeutics’ headquarters in Lausanne, Switzerland, or San Diego, CA. It requests a full time presence on-site. As a condition of employment, you need to have proof of eligibility to work in Switzerland (Swiss work permit or Swiss/European citizenship) or United States of America (U.S. citizenship or work permit/authorization).

Apply with your CV and Cover Letter below. Please specify the position you are applying for and use the “VP-BUSDEV” identifier in your cover letter.

The position comes with an excellent compensation and benefits package.

Key Responsibilities

Develop and execute HAYA’s business development strategy, which reflects the company’s mission and objectives
Identify, evaluate, and pursue strategic partnership opportunities, including licensing deals, collaborations, and M&A prospects
Negotiate on behalf of the company for complex business transactions and provide oversight during the due diligence process
Cultivate relationships with major stakeholders within the biotech/pharma sector, including potential partners, investors, and thought leaders
Work closely with HAYA’s science team to understand the company’s technology platform and pipeline to be able to turn scientific advances into meaningful business opportunities
Team up with R&D, clinical, legal, finance, and other departments on cross-functional projects that support business development initiatives
Keep up to date with industry trends, the competitive landscape and emerging technologies applicable to the areas of focus at HAYA
Represent HAYA at industry conferences and other events to enhance the company’s visibility and network

What We Are Expecting From You:

Advanced degree in life sciences (preferably PhD or MD) with MBA or equivalent business experience
15+ years’ experience in business development, licensing or corporate strategy within the biotech/pharma industry
Demonstrated record of successfully closing major deals and strategic partnerships
Broad understanding of the drug discovery and development process, particularly in RNA therapeutics
Strong analytical and financial skills for modeling
Strong leadership skills, including excellent communication and presentation capabilities
Able to thrive under pressure in an environment full of fast-moving change

On average, candidates must be ready to travel as often as 20-30%.

Who Are We?

We are a team
We stay positive
We love what we do
We respect each other
We communicate and listen
We work hard, smart, as one
We are all about the dark genome
We use cutting edge technologies
We strive for excellence and innovation
We want to reshape precision medicine
We are HAYA Therapeutics

HAYA by the numbers:

38 people working
50% women
50% men
79% PhD’s
18 languages
2 continents

More About Our Approach

We are reprograming cell-states to treat rare and common diseases

Long non-coding RNAs: Unexplored Therapeutic Target Landscape

~98% of the human genome is composed of non-protein coding regions. This portion of the genome, known as the 'dark genome,' is dynamically active, generating thousands of therapeutically unexplored long non-coding RNAs (lncRNAs).

LncRNAs - the information processing units of disease-driving cell states

LncRNAs regulate disease-associated gene pathways and proteins in response to the environment, triggering a disease-associated cell state.

At HAYA we WORK HARD and PLAY HARD!

PATH TO SUCCCESS

Ready to reach new heights? Let's get there, together.

So, wherever you are on your career path, there has never been a better time to join HAYA Therapeutics.